Epidemiology and mortality outcome of carbapenem- and colistin-resistant Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa bloodstream infections

被引:13
作者
Balkhair, A. [1 ]
Al Saadi, K. [1 ]
Al Adawi, B. [2 ]
机构
[1] Sultan Qaboos Univ Hosp, Dept Med, Infect Dis Unit, Muscat, Oman
[2] Oman Med Special Board, Internal Med Program, Muscat, Oman
来源
IJID REGIONS | 2023年 / 7卷
关键词
carbapenem resistance; colistin resistance; bloodstream infection; mortality; Oman;
D O I
10.1016/j.ijregi.2023.01.002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Bloodstream infections caused by carbapenem-resistant Gram-negative bacteria represent a major therapeutic challenge to clinicians worldwide. This study examined the epidemiology of carbapenem and colistin resistance in Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii blood isolates in an academic institution in Oman.Methods: Adult patients with bloodstream infections caused by Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii, between January 1, 2017, and December 31, 2020, were identified. Rates of carbapenem resistance, carbapenem-colistin dual resistance, and 30-day all-cause mortality were examined.Results: 585 non-repeat bloodstream infections due to Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii were identified during the study period. OXA-48 was the most prevalent carbapenemase gene in carbapenem-resistant K. pneumoniae blood isolates. Carbapenem resistance was observed in 160 (27.7%) of blood isolates, with 131 (81.9%) of these being healthcare-onset cases. Carbapenem resistance was highest in Acinetobacter baumannii (80.4%), followed by Klebsiella pneumoniae (46.4%), and Pseudomonas aeruginosa (29.9%). Sixteen (13.4%) of the carbapenem-resistant blood isolates were found to be colistin resistant. Thirty-day all-cause mortality was 68.1% in patients with bloodstream infections caused by carbapenem-resistant isolates, versus 21.3% in patients with bloodstream infections caused by carbapenem-susceptible isolates.Conclusion: The prevalence of carbapenem resistance and carbapenem-colistin dual resistance in Gram-negative blood culture isolates from patients with bloodstream infections is unacceptably high. Patients with bloodstream infections due to carbapenem-resistant isolates had substantially higher mortality.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 24 条
[1]   Molecular mechanisms and prevalence of colistin resistance of Klebsiella pneumoniae in the Middle East region: A review over the last 5 years [J].
Aris, Parisa ;
Robatjazi, Saeedeh ;
Nikkhahi, Farhad ;
Marashi, Seyed Mahmoud Amin .
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 22 :625-630
[2]   Colistin resistance increases 28-day mortality in bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae [J].
Balkan, Ilker Inanc ;
Alkan, Mustafa ;
Aygun, Gokhan ;
Kuskucu, Mert ;
Ankarali, Handan ;
Karagoz, Alper ;
Sen, Sumeyye ;
Arsu, Hatice Yasar ;
Bicer, Mehtap ;
Kaya, Sibel Yildiz ;
Karaali, Ridvan ;
Mete, Bilgul ;
Saltoglu, Nese ;
Tabak, Fehmi .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (10) :2161-2170
[3]   Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend [J].
Balkhair, A. ;
Al-Muharrmi, Z. ;
Al'Adawi, B. ;
Al Busaidi, I. ;
Taher, H. B. ;
Al-Siyabi, T. ;
Al Amin, M. ;
Hassan, K. S. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 85 :10-15
[4]   Global colistin use: a review of the emergence of resistant Enterobacterales and the impact on their genetic basis [J].
Binsker, Ulrike ;
Kaesbohrer, Annemarie ;
Hammerl, Jens A. .
FEMS MICROBIOLOGY REVIEWS, 2022, 46 (01)
[6]  
Clinical and Laboratory Standards Institute (CLSI), 2021, CLSI supplement M100, DOI DOI 10.1093/OFID/OFV050
[7]   The crisis of carbapenemase-mediated carbapenem resistance across the human-animal-environmental interface in India [J].
Das, Surojit .
INFECTIOUS DISEASES NOW, 2023, 53 (01)
[8]   A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options [J].
Elshamy, Ann A. ;
Aboshanab, Khaled M. .
FUTURE SCIENCE OA, 2020, 6 (03)
[9]  
European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2014, BREAKPOINT TABLES IN
[10]   Extended Spectrum- and Carbapenemase-Based β-Lactam Resistance in the Arabian Peninsula-A Descriptive Review of Recent Years [J].
Hays, John Philip ;
Safain, Kazi Sarjana ;
Almogbel, Mohammed Suliman ;
Habib, Ihab ;
Khan, Mushtaq Ahmad .
ANTIBIOTICS-BASEL, 2022, 11 (10)